Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2006 | 06-2005 | 06-2004 | 06-2003 | 06-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,189 | -39,978 | -40,620 | -24,825 | -13,989 |
| Depreciation Amortization | 6,855 | 6,092 | 5,766 | 5,275 | 4,496 |
| Accounts receivable | -5,698 | -5,486 | -2,947 | -7,286 | -2,038 |
| Accounts payable and accrued liabilities | -93 | 3,959 | -3,516 | 1,842 | 842 |
| Other Working Capital | -1,408 | 6,076 | 1,944 | -27,516 | -7,438 |
| Other Operating Activity | 10,506 | 6,033 | 8,493 | 5,970 | 1,815 |
| Operating Cash Flow | $-28,027 | $-23,304 | $-30,880 | $-46,540 | $-16,312 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,680 | -6,736 | -3,883 | -8,036 | -6,853 |
| Purchase Of Investment | -165,519 | -44,603 | -52,730 | -51,784 | -92,239 |
| Sale Of Investment | 100,470 | 70,956 | 25,487 | 50,707 | 137,181 |
| Other Investing Activity | -100 | -100 | -100 | -2,850 | 0 |
| Investing Cash Flow | $-72,829 | $19,517 | $-31,226 | $-11,963 | $38,089 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 149,920 | 2,466 | 51,333 | 59,039 | 3,353 |
| Financing Cash Flow | $149,920 | $2,466 | $51,333 | $59,039 | $3,353 |
| Beginning Cash Position | 49,509 | 50,830 | 61,603 | 61,067 | 35,937 |
| End Cash Position | 98,573 | 49,509 | 50,830 | 61,603 | 61,067 |
| Net Cash Flow | $49,064 | $-1,321 | $-10,773 | $536 | $25,130 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,027 | -23,304 | -30,880 | -46,540 | -16,312 |
| Capital Expenditure | -7,680 | -6,736 | -3,883 | -8,036 | -6,853 |
| Free Cash Flow | -35,707 | -30,040 | -34,763 | -54,576 | -23,165 |